e-Drug3D 158 |
ACETYLDIGITOXIN DISCONTINUED
|
cas 1111-39-3 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters |
Target TARGET NA-K ATPASE |
DrugCentral Sodium,potassium-transporting ATPase UNIPROT P05023 ATP1A1 |
Download SDF file | [(2R,3R,4S,6S)-3-hydroxy-6-[(2R,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[[(5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate Formula: Calculated chemical properties: MW 806.96 NB_atoms 57 XLogP 3.82 PSA 181.032 NB_HD 4 NB_HA 14 fsp3 0.91 Lipinski(0=no;1=yes) 0 |
FDA NDA 009436 (pdf not found) INN (ACETYLDIGITOXIN) ACYLANID (NOVARTIS) APPROVAL= AP YEAR= 1975 DISCONTINUED |
Other links: |